Workflow
A Look at Pharma ETFs After Q4 Earnings
BMYBristol-Myers Squibb(BMY) Zacks Investment Research·2024-02-13 03:01

The fourth-quarter results of the healthcare sector have been unimpressive, with earnings of companies that have reported so far down 17.7% despite 7% revenue growth. The earnings beat ratio of 79.4% and revenue beat ratio of 85.3% are assuring, though. Combining the actual results with the estimates for the still-to-report companies, the total earnings of the sector are expected to decline 18.2% despite revenue growth of 5.3%.However, many industry bigwigs reported solid results, with some beating on earni ...